Fewer lab animals, better drugs: This startup wants to fix how experiments get designed
Drug researchers just cut lit review from 30 days to 1 hour. ModernVivo's AI reads millions of animal studies to auto-design experiments.
Why it matters
AI is automating the knowledge-synthesis bottleneck in preclinical research. For pharma teams and biotech operators, this shifts resource allocation and experiment velocity — a measurable productivity win in a high-stakes, compliance-heavy workflow.
The key facts
10 to knowModernVivo uses AI to analyze millions of published animal studies
Customers reduced literature review time from ~1 month to ~1 hour
Software automates experiment design step traditionally done manually
Seattle-based startup
Target: drug researchers and preclinical teams
ModernVivo uses AI to synthesize millions of published animal studies
Literature review compressed from ~1 month to ~1 hour for customers
Target use case: experiment design in preclinical drug research
Founded in Seattle
Product addresses both researcher efficiency and reduction in animal testing
Go to the source
GeekWiregeekwire.com
Publisher excerpt: ModernVivo's software reads millions of published animal studies to help drug researchers design their own experiments, work that has traditionally meant weeks of manual literature review. The Seattle company says customers who once spent a month on that step now spend as little as an hour.